19.11.2012 Views

Research Report 2000 - MDC

Research Report 2000 - MDC

Research Report 2000 - MDC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

developmental pathway that may<br />

involve the Myb onco-protein. In<br />

support of such a speculation are our<br />

observations that murine GBX2 and<br />

FGF-2 knock-outs display epistatic<br />

hematopoietic defects and GBX2 and<br />

FGF-2 are co-expressed in<br />

hematopoietic cell lines. We are,<br />

therefore, searching for a link between<br />

GBX2, FGF-2, its receptor, and Myb.<br />

Interestingly, the same mutations in<br />

leukemogenic Myb that constitutively<br />

activate GBX2 concomitantly<br />

abrogate the collaboration between<br />

Myb and C/EBP. Accordingly, they<br />

are loss-of-function mutations for<br />

C/EBP collaboration. Since C/EBP<br />

induces cell differentiation and<br />

proliferation arrest, it appears that the<br />

oncoprotein abolishes the function of<br />

a genetic switch that controls terminal<br />

differentiation of myeloid cells.<br />

Translational regulation of<br />

transcription factors<br />

Several protein isoforms arise from<br />

both GBX2 and C/EBP mRNAs by<br />

alternative initiation of protein<br />

translation at different start codons.<br />

The isoforms give rise to DNA<br />

regulatory proteins with entirely<br />

different functions. In the case of<br />

C/EBPs, full-length proteins are transactivators<br />

while an internally initiated<br />

protein is a repressor. The C/EBP<br />

transactivator proteins mediate<br />

proliferation arrest and cellular<br />

differentiation, whereas the repressor<br />

permits proliferation. Long and short<br />

protein isoforms are also generated<br />

from the GBX2 mRNA. Unlike<br />

C/EBPs, however, long GBX2<br />

isoforms are repressors whereas the<br />

short form is an activator. The<br />

activator GBX2 supports expression<br />

of at least one cytokine that promotes<br />

precursor cell proliferation. Thus,<br />

internal start site usage will support<br />

growth because short, growthpromoting<br />

isoforms replace the long,<br />

C/EBPα<br />

E7<br />

Differentiation Proliferationarrest<br />

differentiation-promoting isoforms of<br />

C/EBP and GBX2. In contrast,<br />

preferential initiation from the first<br />

start codons will support<br />

differentiation by increasing the pool<br />

of long isoforms. Site-directed<br />

mutagenesis has revealed that<br />

translation initiation control relies on<br />

a highly conserved small upstream<br />

open reading frame (uORF). We have<br />

now begun a detailed analysis of the<br />

relationship between GBX2 and<br />

C/EBP isoform expression, translation<br />

initiation factor activity, regulation by<br />

uORF, and the biological functions of<br />

protein isoforms. From our results, we<br />

found that two differentially initiated<br />

C/EBPβ isoforms display striking<br />

differences in recruitment of the<br />

SWI/SNF complex. It is anticipated<br />

that pathways and factors involved in<br />

the control of translational initiation<br />

are important regulators of<br />

hematopoiesis and may be novel<br />

targets for innovative drug therapies.<br />

Figure 27: Proliferation in terminally<br />

differentiated adipocytes is induced by the E7<br />

oncogene. Cell division is evident by separating<br />

metaphase chromosomes and terminal fat cell<br />

differentiation by storage of fat droplets in the<br />

cytoplasm. The model underneath indicates that<br />

the E7 oncoprotein uncouples C/EBP programs<br />

for proliferationarrest and for differentiation.<br />

65

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!